首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1736704

全球顱內支架市場：市場規模（依適應症、產品類型、最終用戶和地區分類）、未來預測

Global Intracranial Stents Market Size By Disease Indication, By Product Type, By End-User, By Geographic Scope And Forecast

出版日期: 2025年05月07日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

顱內支架的市場規模及預測

2024 年顱內支架市場規模為 4.3717 億美元，預計到 2032 年將達到 8.4896 億美元，2026 年至 2032 年的複合年成長率為 8.65%。

顱內支架是一種小型管狀醫療設備，植入腦血管後可治療各種腦血管疾病，特別適用於血流不規則或動脈狹窄的疾病。這些支架通常由生物相容性材料製成，例如鎳鈦合金或鈷鉻合金，並可自膨脹或球囊擴張。支架用於為薄弱或狹窄的動脈提供結構支撐，保持其暢通，並確保充足的血流流向腦部各個區域。這項技術對於預防中風、修復動脈瘤以及治療腦動脈硬化等疾病至關重要。

顱內支架用於治療多種疾病。在治療腦動脈瘤時，支架用於維持血管壁並防止破裂。它們也用於治療缺血性中風，尤其是在需要進行機械血栓切除術以去除血栓的情況下。此外，顱內支架在治療腦動脈狹窄方面發揮著至關重要的作用，它可以擴張狹窄的動脈並恢復正常的血流。這些支架與血管造影術等最新的影像技術結合使用，以確保精確放置並有效恢復血管的完整性。

材料科學、影像技術和微創手術的進步。創新可能集中於開發具有更高生物相容性和藥物釋放型能力的支架，以降低血管再阻塞和血栓症的風險。此外，將智慧技術融入支架，例如即時監測血流和血管狀態的感測器，可以透過提供持續數據並實現腦血管疾病的預防性管理，從而改變患者照護。隨著研究的進展，腦支架的應用預計將會擴展，為患有各種神經血管疾病的患者提供更好的治療效果，並將其應用擴展到新的治療領域。

全球顱內支架市場動態

影響全球顱內支架市場的關鍵市場動態是：

主要市場促進因素：

腦血管疾病發生率上升：中風和動脈粥狀硬化等腦血管疾病發生率的上升推動了顱內支架市場的發展。隨著世界人口老化，這些疾病的盛行率不斷上升，需要顱內支架置入術等現代醫療技術來妥善管理和治療。這一趨勢在人口老化的富裕國家尤其普遍，這導致對有效腦血管治療的需求迅速增加。

醫學影像技術的進步：高解析度磁振造影（MRI）和CT血管造影術等醫療圖像技術徹底改變了腦血管疾病的識別和治療。影像技術的進步使得顱內支架的放置更加精準，從而提高了其療效和安全性。這項技術進步使臨床醫生能夠更好地觀察和導航複雜的腦動脈，從而促進顱內支架置入治療，降低手術風險，並改善患者預後。

支架設計創新：支架設計的新進展，例如藥物釋放型和生物可吸收支架的出現，正在推動顱內支架市場的發展。這些發展旨在提高支架療效，降低血管再阻塞風險，並改善患者的長期預後。生物相容性和柔韌性更高的新材料和新設計的出現，正在推動顱內支架的應用，使治療更加成功，並擴大患者群體。

政府的支持性舉措和政策：這些旨在改善醫療保健效果的政策正在推動顱內支架市場的成長。資助研發、補貼創新醫療設備以及改善公共醫療體系的計畫都促進了顱內支架的使用率的提升。這些政策不僅有助於擴大市場，也使更多人能夠獲得尖端的神經血管治療。

主要挑戰

患者選擇的複雜性：選擇合適的顱內置入術患者需要考慮多個方面，包括病變形態、血管解剖和合併症。患者選擇標準的複雜性可能會限制顱內支架的廣泛應用，並且需要進行廣泛的考慮以最佳化治療結果。

技能和訓練要求：介入神經放射學需要豐富的專業知識和訓練才能實施顱內支架置入置入術，包括先進的影像技術和導管介入手術。技術人員的短缺可能會阻礙該技術的廣泛應用和品質保證。

新興替代療法和技術：血流轉向器和外科手術等替代療法的進步對顱內支架置入術術構成了競爭威脅。為了在不斷變化的神經血管內治療環境中保持商業性可行性，支架技術必須不斷創新並具有適應性。

併發症和不利事件風險：顱內置入術的相關風險包括血栓症、出血和血管穿孔，這些風險可能導致嚴重的神經系統後果。管理這些風險需要經驗豐富的醫生和專業的醫療設施，確保在不同患者群體中一致的安全性和有效性也極具挑戰性。

主要趨勢：

藥物釋放型技術的整合：藥物釋放型顱內支架的開發旨在透過將治療藥物直接釋放到治療部位來減少血管再阻塞，從而可能提高裸金屬支架的長期療效。

新興市場和可及的醫療保健：新興經濟體不斷成長的醫療保健基礎設施和不斷增加的可支配收入正在推動顱內支架的採用，從而改善獲得最新腦血管治療的機會。

監管發展和標準化：簡化監管管道和製定顱內支架使用一致建議的努力將透過確保設備在製造和臨床環境中的安全性、有效性和品質來促進市場發展。

個人化醫療方法：基因分析和生物標記發現的進步正在開闢個人化治療選擇，利用顱內支架根據個別患者特徵和疾病狀況進行客製化。

Intracranial stents are small, tube-like medical devices that are implanted within the brain's blood vessels to treat a variety of cerebrovascular disorders, particularly those characterized by irregular blood flow or narrowed arteries. These stents are often made of biocompatible materials like nitinol or cobalt-chromium alloy and can either self-expand or expand with a balloon. They are utilized to offer structural support to less effective or restricted arteries, keeping them open and allowing enough blood flow to brain areas. This technique is critical for preventing strokes, repairing aneurysms, and managing diseases like cerebral atherosclerosis.

Intracranial stents are used to treat a variety of medical disorders. The treatment of cerebral aneurysms is when stents are used to maintain the vascular wall and prevent rupture. They are also used to manage ischemic stroke, particularly when mechanical thrombectomy is required to remove a blood clot. Furthermore, intracranial stents play an important role in the treatment of cerebral artery stenosis by widening limited arteries and restoring normal blood flow. These stents are used with modern imaging techniques, such as angiography, to ensure exact placement and effectiveness in restoring vascular integrity.

Advancements in material science, imaging technologies, and minimally invasive surgery. Innovations are likely to focus on developing stents with improved biocompatibility and drug-eluting capabilities to lower the risk of restenosis and thrombosis. Furthermore, incorporating smart technology into stents, such as sensors for real-time monitoring of blood flow and vessel status, has the potential to transform patient care by giving continuous data and allowing for proactive management of cerebrovascular illnesses. As research advances, the use of cerebral stents is projected to grow, providing better outcomes for patients with a broader spectrum of neurovascular disorders and potentially expanding their usage to new therapeutic areas.

Global Intracranial Stents Market Dynamics

The key market dynamics that are shaping the global intracranial stents market include:

Key Market Drivers:

Rising Incidence of Cerebrovascular Diseases: The increasing incidence of cerebrovascular diseases, including stroke and atherosclerosis, is driving the intracranial stents market. As the world's population ages, the prevalence of these disorders increases, need modern medical techniques such as intracranial stenting to properly manage and treat them. This tendency is especially evident in affluent countries with aging populations, where the demand for effective cerebrovascular treatments is quickly increasing.

Advancements in Medical Imaging Technology: Medical imaging technology, such as high-resolution MRI and CT angiography, has transformed the identification and treatment of cerebrovascular diseases. Enhanced imaging enables more precise implantation of intracranial stents, improving their efficacy and safety. This technological advancement has facilitated the use of intracranial stenting treatments because clinicians can now better observe and navigate intricate cerebral arteries, lowering procedural risks and increasing patient outcomes.

Technological Innovations in Stent Design: New developments in stent design, such as the emergence of drug-eluting and bioresorbable stents, are moving the intracranial stents market ahead. These developments seek to improve stent efficacy, lower the risk of restenosis, and improve long-term patient outcomes. The arrival of new materials and designs with improved biocompatibility and flexibility has boosted the use of intracranial stents, making treatments more successful and expanding the patient pool.

Supportive Government Initiatives and Policies: These policies aimed at improving healthcare outcomes are driving growth in the intracranial stents market. Programs that fund research and development, give subsidies for innovative medical devices, and improve public healthcare systems all contribute to the rising use of intracranial stents. These policies not only promote market expansion but also ensure that a larger portion of the public has access to cutting-edge cerebrovascular treatments.

Key Challenges:

Complexity of Patient Selection: To select appropriate candidates for intracranial stenting, several aspects must be considered, including lesion morphology, vascular anatomy, and comorbidities. The difficulty of patient selection criteria can limit the broad use of intracranial stents, necessitating extensive review to optimize treatment outcomes.

Skill and Training Requirements: Neurointerventionalists must have different expertise and training to perform intracranial stenting, which includes advanced imaging techniques and catheter-based treatments. The scarcity of skilled personnel can impede widespread adoption and quality assurance.

Emerging Alternatives and Technologies: Advancements in alternative therapies, such as flow diverters and surgical procedures, pose competitive threats to intracranial stenting. To remain commercially relevant in the ever-changing landscape of cerebrovascular therapies, stent technology must be constantly innovated and adaptable.

Risk of Complications and Adverse Events: Risks associated with intracranial stenting procedures include thrombosis, bleeding, and blood vessel perforation which can cause severe neurological consequences. Managing these risks necessitates the use of highly skilled practitioners and specialized facilities, making it difficult to ensure consistent safety and efficacy across diverse patient populations.

Key Trends:

Integration of Drug-Eluting Technologies: The development of drug-eluting intracranial stents intends to reduce restenosis by releasing therapeutic drugs directly at the treatment site, with the potential for improved long-term efficacy over bare-metal stents.

Emerging Markets and Accessible Healthcare: Growing healthcare infrastructure and rising disposable budgets in emerging nations are encouraging increased adoption of intracranial stents, hence improving access to modern cerebrovascular treatments.

Regulatory Advancements and Standardization: Efforts to streamline regulatory channels and develop consistent recommendations for intracranial stent use drive market growth by guaranteeing device safety, efficacy, and quality in both production and clinical practice.

Personalized Medicine Approaches: Advances in genetic profiling and biomarker discovery are opening the way for individualized treatment options with intracranial stents that are matched to individual patient characteristics and illness profiles.

Global Intracranial Stents Market Regional Analysis

Here is a more detailed regional analysis of the global intracranial stents market:

North America:

North America dominates the global intracranial stents market, thanks to its strong healthcare infrastructure and broad use of new medical technology. The region benefits from a mature ecosystem of healthcare providers and research institutes that specialize in neurovascular treatments.

Major intracranial stent manufacturers are located or have large operations in North America, which promotes innovation and ensures access to cutting-edge therapies. The high frequency of cerebrovascular illnesses and neurological disorders, combined with robust regulatory frameworks that support medical device approvals, reinforces North America's dominance in the intracranial stents industry.

According to the Medicare Coverage Database, the intracranial arteries contribute to 8-10% of all ischemic strokes in the United States (Thijs et al., 2000). Intracranial artery stenosis is responsible for around 70,000 to 90,000 strokes or transient ischemic episodes (TIAs) per year (Chimowitz et al., 2005). The major intracranial arteries are the anterior and middle cerebral arteries, the basilar artery, and the vertebral artery's intracranial parts.

Asia Pacific:

The Asia Pacific region's intracranial stents market is expected to grow rapidly due to a combination of demographic and economic factors. A growing population with higher healthcare requirements, combined with rising occurrences of cerebrovascular illnesses and neurological problems, drives demand for improved neuro interventional treatments such as intracranial stenting. Furthermore, there is a growing awareness of preventive healthcare practices, which promote early detection and intervention, increasing the region's use of intracranial stents.

The growing middle class in Asia Pacific countries contributes significantly to market growth. With more disposable income, this demographic group desires access to modern medical technologies and procedures, such as intracranial stenting.

Increasing expenditures in healthcare infrastructure and the construction of specialist neurology clinics are improving access to neuro interventional operations, meeting Asia Pacific's growing demand for effective cerebrovascular therapies. These factors highlight the region's emergence as a key growth hub in the intracranial stents market.

Global Intracranial Stents Market: Segmentation Analysis

The Global Intracranial Stents Market is Segmented on the basis of Disease Indication, Product Type, End-User, And Geography.

Intracranial Stents Market, By Disease Indication

Brain Aneurysm
Intracranial Stenosis

Based on Disease Indication, the market is fragmented into Brain Aneurysm and Intracranial Stenosis. In the Intracranial Stents market, Intracranial Stenosis is expected to be the fastest-expanding category. This is being driven by the increasing prevalence of cerebrovascular disorders, which are a key risk factor for stenosis. Increased awareness and developments in diagnostic tools are allowing for earlier detection of stenosis, necessitating the insertion of stents to prevent stroke. Brain aneurysms are anticipated to have the largest share due to proven treatment approaches including stents, although stenosis is growing at a quicker rate due to an expanding pool of patients requiring this treatment.

Intracranial Stents Market, By Product Type

Stent-Assisted Coil Embolization
Balloon Expanding Stents
Self-Expanding Stents

Based on Product Type, the market is segmented into Stent-Assisted Coil Embolization, Balloon Expanding Stents, and Self-Expanding Stents.

Self-expanding stents are likely to take over due to their ease of use and adaptability to a variety of vessel geometries. However, balloon-expanding stents are predicted to be the most rapidly developing category. This is because they provide accurate positioning and improved control during deployment, which is increasingly important for complex processes.

Intracranial Stents Market, By End-User

Hospitals
Ambulatory Surgical Centers

Based on End-Users, the market is segmented into Hospitals and Ambulatory Surgical Centers. Hospitals are now the dominant segment in the intracranial stents market, owing to their well-equipped facilities and specialist surgeons for difficult intracranial stent surgeries. However, ambulatory surgery facilities are likely to be the most rapidly developing segment. Advances in minimally invasive stent installation techniques, combined with rising costs, have made these facilities a more cost-effective choice for certain procedures.

Intracranial Stents Market, By Geography

North America
Europe
Asia Pacific
Rest of the World
On the basis of Geography, the Global Intracranial Stents Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to be the dominating area in the intracranial stents market. This is due to a mix of variables, including high healthcare costs, established infrastructure, and a big patient population with cerebrovascular illnesses. Asia Pacific is likely to experience the most rapid expansion. Rising disposable incomes, more understanding of stroke prevention, and an aging population making these conditions more likely all contribute to this trend.

Key Players

The "Global Intracranial Stents Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boston Scientific Corporation, DePuy Synthes, Penumbra, Inc., Medtronic, Terumo Corporation, Phenox, Acandis, Stryker Corporation, Cook Medical, and MicroPort Scientific. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Intracranial Stents Market Recent Developments
In September 2022, Phenox GmbH launched the pEGASUS HPC stent globally at the ESMINT 2022 congress in Nice, France. The pEGASUS HPC stent is the first stent of its kind to introduce coating technology for the treatment of ICAD and aneurysms.
In June 2022, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, announced a CE- certified fourth-generation flow diverter, PipelineTM Vantage with Shield Technology for endovascular treatment of brain aneurysms

1 INTRODUCTION OF GLOBAL INTRACRANIAL STENTS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL INTRACRANIAL STENTS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL INTRACRANIAL STENTS MARKET, BY DISEASE INDICATION

5.1 Overview
5.2 Brain Aneurysm
5.3 Intracranial Stenosis

6 GLOBAL INTRACRANIAL STENTS MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Stent-Assisted Coil Embolization
6.3 Balloon Expanding Stents
6.4 Self-Expanding Stents

7 GLOBAL INTRACRANIAL STENTS MARKET, BY END USER

7.1 Overview
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Others

8 GLOBAL INTRACRANIAL STENTS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East

9 GLOBAL INTRACRANIAL STENTS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Boston Scientific Corporation
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 DePuy Synthes
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Medtronic
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Terumo Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Phenox
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Acandis
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Stryker Corporation
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Cook Medical
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 MicroPort Scientific
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments